Comparison of serum CA72-4, CEA, TPA, CA19-9 and CA125 levels in gastric cancer patients and correlation with recurrence

I. Rue Lai, Wei Jei Lee, Ming Te Huang, Hshu Hshing Lin

Research output: Contribution to journalArticle

69 Citations (Scopus)

Abstract

Background/Aims: Serum tumor markers were investigated as prognostic factors for recurrence in patients with gastric cancers. Methodology: Preoperative serum levels of CEA, CA72-4, CA19-9, TPA and CA125 were sampled in 196 patients with gastric cancers undergoing curative surgery. The results were compared with the clinical recurrence and various clinicopathological factors. Results: CA72-4, CEA, CA19-9, TPA and CA125 had sensitivities of 16.4%, 31.4%, 16.1%, 31.6%, and 6%, respectively. Sensitivity of two combinations was as high as 56.5%. Seventy-seven patients (39.9%) had clinical recurrence in the follow-up periods. For those with preoperatively elevated serum tumor markers, 38% (12/32) had CA72-4, 42% (13/31) had CA19-9, 48% (29/60) and had CEA, 54% (6/11) had CA125, and 62% (37/61) had TPA, and remained disease-free. Univariate analysis showed that TNM staging, Tumor size, Borrmann classification of tumor growth, and preoperative serum CA72-4 level were correlated with recurrence of disease. Multivariate analysis showed that independent prognostic factor of recurrence was TNM staging (P=0.0007). Conclusions: Preoperative serum CA72-4 level is correlated with staging of disease, but is not an independent predictor for clinical recurrence of disease in patients with gastric cancers that undergo surgery.

Original languageEnglish
Pages (from-to)1157-1160
Number of pages4
JournalHepato-Gastroenterology
Volume49
Issue number46
Publication statusPublished - 2002
Externally publishedYes

Fingerprint

Stomach Neoplasms
Recurrence
Serum
Neoplasm Staging
Tumor Biomarkers
Biomarkers
Neoplasms
Multivariate Analysis
Growth

Keywords

  • CA72-4
  • Gastric cancer

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Comparison of serum CA72-4, CEA, TPA, CA19-9 and CA125 levels in gastric cancer patients and correlation with recurrence. / Lai, I. Rue; Lee, Wei Jei; Huang, Ming Te; Lin, Hshu Hshing.

In: Hepato-Gastroenterology, Vol. 49, No. 46, 2002, p. 1157-1160.

Research output: Contribution to journalArticle

@article{d560703b6bc242d88c225234208a3451,
title = "Comparison of serum CA72-4, CEA, TPA, CA19-9 and CA125 levels in gastric cancer patients and correlation with recurrence",
abstract = "Background/Aims: Serum tumor markers were investigated as prognostic factors for recurrence in patients with gastric cancers. Methodology: Preoperative serum levels of CEA, CA72-4, CA19-9, TPA and CA125 were sampled in 196 patients with gastric cancers undergoing curative surgery. The results were compared with the clinical recurrence and various clinicopathological factors. Results: CA72-4, CEA, CA19-9, TPA and CA125 had sensitivities of 16.4{\%}, 31.4{\%}, 16.1{\%}, 31.6{\%}, and 6{\%}, respectively. Sensitivity of two combinations was as high as 56.5{\%}. Seventy-seven patients (39.9{\%}) had clinical recurrence in the follow-up periods. For those with preoperatively elevated serum tumor markers, 38{\%} (12/32) had CA72-4, 42{\%} (13/31) had CA19-9, 48{\%} (29/60) and had CEA, 54{\%} (6/11) had CA125, and 62{\%} (37/61) had TPA, and remained disease-free. Univariate analysis showed that TNM staging, Tumor size, Borrmann classification of tumor growth, and preoperative serum CA72-4 level were correlated with recurrence of disease. Multivariate analysis showed that independent prognostic factor of recurrence was TNM staging (P=0.0007). Conclusions: Preoperative serum CA72-4 level is correlated with staging of disease, but is not an independent predictor for clinical recurrence of disease in patients with gastric cancers that undergo surgery.",
keywords = "CA72-4, Gastric cancer",
author = "Lai, {I. Rue} and Lee, {Wei Jei} and Huang, {Ming Te} and Lin, {Hshu Hshing}",
year = "2002",
language = "English",
volume = "49",
pages = "1157--1160",
journal = "Acta hepato-splenologica",
issn = "0172-6390",
publisher = "H.G.E. Update Medical Publishing Ltd.",
number = "46",

}

TY - JOUR

T1 - Comparison of serum CA72-4, CEA, TPA, CA19-9 and CA125 levels in gastric cancer patients and correlation with recurrence

AU - Lai, I. Rue

AU - Lee, Wei Jei

AU - Huang, Ming Te

AU - Lin, Hshu Hshing

PY - 2002

Y1 - 2002

N2 - Background/Aims: Serum tumor markers were investigated as prognostic factors for recurrence in patients with gastric cancers. Methodology: Preoperative serum levels of CEA, CA72-4, CA19-9, TPA and CA125 were sampled in 196 patients with gastric cancers undergoing curative surgery. The results were compared with the clinical recurrence and various clinicopathological factors. Results: CA72-4, CEA, CA19-9, TPA and CA125 had sensitivities of 16.4%, 31.4%, 16.1%, 31.6%, and 6%, respectively. Sensitivity of two combinations was as high as 56.5%. Seventy-seven patients (39.9%) had clinical recurrence in the follow-up periods. For those with preoperatively elevated serum tumor markers, 38% (12/32) had CA72-4, 42% (13/31) had CA19-9, 48% (29/60) and had CEA, 54% (6/11) had CA125, and 62% (37/61) had TPA, and remained disease-free. Univariate analysis showed that TNM staging, Tumor size, Borrmann classification of tumor growth, and preoperative serum CA72-4 level were correlated with recurrence of disease. Multivariate analysis showed that independent prognostic factor of recurrence was TNM staging (P=0.0007). Conclusions: Preoperative serum CA72-4 level is correlated with staging of disease, but is not an independent predictor for clinical recurrence of disease in patients with gastric cancers that undergo surgery.

AB - Background/Aims: Serum tumor markers were investigated as prognostic factors for recurrence in patients with gastric cancers. Methodology: Preoperative serum levels of CEA, CA72-4, CA19-9, TPA and CA125 were sampled in 196 patients with gastric cancers undergoing curative surgery. The results were compared with the clinical recurrence and various clinicopathological factors. Results: CA72-4, CEA, CA19-9, TPA and CA125 had sensitivities of 16.4%, 31.4%, 16.1%, 31.6%, and 6%, respectively. Sensitivity of two combinations was as high as 56.5%. Seventy-seven patients (39.9%) had clinical recurrence in the follow-up periods. For those with preoperatively elevated serum tumor markers, 38% (12/32) had CA72-4, 42% (13/31) had CA19-9, 48% (29/60) and had CEA, 54% (6/11) had CA125, and 62% (37/61) had TPA, and remained disease-free. Univariate analysis showed that TNM staging, Tumor size, Borrmann classification of tumor growth, and preoperative serum CA72-4 level were correlated with recurrence of disease. Multivariate analysis showed that independent prognostic factor of recurrence was TNM staging (P=0.0007). Conclusions: Preoperative serum CA72-4 level is correlated with staging of disease, but is not an independent predictor for clinical recurrence of disease in patients with gastric cancers that undergo surgery.

KW - CA72-4

KW - Gastric cancer

UR - http://www.scopus.com/inward/record.url?scp=0036021382&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036021382&partnerID=8YFLogxK

M3 - Article

C2 - 12143226

AN - SCOPUS:0036021382

VL - 49

SP - 1157

EP - 1160

JO - Acta hepato-splenologica

JF - Acta hepato-splenologica

SN - 0172-6390

IS - 46

ER -